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ABSTRACT Tuberculosiscontinuestobeamajorpublichealthprobleminmanypartsoftheworld.Signiﬁcantobstaclesincon-
trollingtheepidemicarethelengthoftreatmentandthelargereservoiroflatentlyinfectedpeople.Bacteriaformdormant,drug-
tolerantpersistercells,whichmayberesponsibleforthedifﬁcultyintreatingbothacuteandlatentinfections.Weﬁndthatin
Mycobacterium tuberculosis, low numbers of drug-tolerant persisters are present in lag and early exponential phases, increasing
sharplyatlateexponentialandstationaryphasestomakeup~1%ofthepopulation.Thissuggeststhatpersisterformationis
governedbybothstochasticanddeterministicmechanisms.Inordertoisolatepersisters,anexponentiallygrowingpopulation
wastreatedwith D-cycloserine,andcellssurvivinglysiswerecollectedbycentrifugation.Atranscriptomeofpersisterswasob-
tainedbyusinghybridizationtoanAffymetrixarray.Thetranscriptomeshowsdownregulationofmetabolicandbiosynthetic
pathways,consistentwithacertaindegreeofdormancy.Asetofgeneswasupregulatedinpersisters,andthesearelikelyin-
volvedinpersisterformationandmaintenance.Acomparisonofthepersistertranscriptomewithtranscriptomesobtainedfor
several in vitro dormancy models identiﬁed a small number of genes upregulated in all cases, which may represent a core dor-
mancyresponse.
IMPORTANCE It is estimated that every third person on the planet is infected with Mycobacterium tuberculosis. The two major
problems in controlling M. tuberculosis are the length of the treatment and the large reservoir of latently infected people. Dor-
mant persister cells may be responsible for both problems. We ﬁnd that M. tuberculosis produces persisters in vitro in a growth
phase-dependentmanner.Persisterswereisolatedfromanexponentiallygrowingpopulation,andtheirtranscriptomeshowsa
distinct pattern of dormancy. These results give the ﬁrst insight into M. tuberculosis persisters and point to possible mechanisms
responsiblefortheirformation.
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T
uberculosisremainsamajorworldwidepublichealthproblem
in spite of the availability of antibiotics that show excellent
activity against the pathogen in vitro (1, 2). The World Health
Organization estimates that a third of the world population is
infected with Mycobacterium tuberculosis (3). In 2009, approxi-
mately 1.7 million people died from tuberculosis (2). Two of the
main problems in M. tuberculosis control are the lengthy treat-
ment and the enormous reservoir of latent carriers. The current
“short-course” chemotherapy includes a combination of four an-
tibiotics (isoniazid, rifampin, pyrazinamide, and ethambutol)
that needs to be taken for 2 months, followed by isoniazid and
rifampin for an additional 4 months. An even longer treatment
course is required for curing the latent form, up to 9 months (4).
Becauseapersistentpopulationofpathogensremainsuntillatein
treatment, incomplete therapy is common and has resulted in the
rise of multidrug-resistant and extensively drug-resistant tuber-
culosis (5–7). A common explanation for the need for lengthy
treatment is that all or part of the population enters a nonrepli-
cating persistent state characterized by some degree of dormancy,
with the bacilli becoming tolerant to antibiotics (8–10). Some
lines of evidence suggest that persistent bacteria might reside in
the granuloma, a lesion of immune cells that creates a microenvi-
ronment for the residing M. tuberculosis cells (11, 12). The gran-
uloma environment imposes several stressful conditions on the
resident bacilli, including low pH, NO, hypoxia, and limited nu-
trients(8,10,13).Allofthesefactorshavebeenshowntoproduce
a nonreplicating state in vitro (10, 14–17). In these model experi-
ments with stress factors, the entire population ceased to grow,
which is probably typical of the pathogen in the latent state of
infection. However, it remains unclear why it is so difﬁcult to
eradicate the pathogen from a growing population in an acute
infection.
Allpathogensexaminedsofarproducedormantpersistercells
ingrowingexponentialcultures(18),althoughvirtuallynothingis
known about these cells in M. tuberculosis. Persisters are highly
tolerant to antibiotics, and their presence may very well explain
the recalcitrance of tuberculosis to therapy in both acute and la-
tent infections. Importantly, persisters are not mutants but are
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richia coli, Staphylococcus aureus, and Pseudomonas aeruginosa
make up a small fraction of an exponential population, ~105,
suggesting that their formation is due to stochastic expression of
persistergenes(20).Experimentsbasedontime-lapsemicroscopy
showed that nongrowing persister cells form before the addition
of antibiotics (21). Sorting of an E. coli population expressing
degradable green ﬂuorescent protein under the control of a ribo-
somalpromoterrevealedthepresenceofasmallsubpopulationof
dimcellstoleranttoantibiotics(22).Thissuggestedthatpersisters
have limited translation and are dormant. The transcriptome of
isolated persisters indeed showed downregulation of biosynthetic
functions and pointed to a possible class of genes that can induce
dormancy. These are toxin/antitoxin (TA) modules, which are
widely spread in bacteria. A TA system consists of a stable toxin,
whichinhibitsanessentialcellularfunction,andalabileantitoxin.
In E. coli, gain-of-function mutations in the HipA toxin generate
high-persistence (hip) mutants (23, 24). HipA is a protein kinase
which phosphorylates EF-Tu, inhibiting translation (25, 26). The
RelE toxin inhibits translation by a different mechanism; it is an
mRNA endonuclease. Ectopic overexpression of RelE produces
drug-tolerantpersisters(27).Similarly,overexpressionofanother
E. coli mRNA endonuclease, the MazF toxin, also leads to the
formationofpersisters(28).EctopicexpressionofthreeM.tuber-
culosis RelE homologs also produces drug-tolerant cells (29). TA
modules are highly redundant: there are more than 20 of them in
E. coli (30–32) and more than 65 in M. tuberculosis (TADB; http:
//bioinfo-mml.sjtu.edu.cn/TADB/browse.php). Consistent with
this observation, screens of E. coli and knockout libraries did not
identify a single strain lacking persisters (33, 34).
Whilepersistersformstochastically,theirnumbersrisesharply
as population density increases, reaching 1% in stationary-phase
cultures (20). This indicates a deterministic component of per-
sisterformation.Thenatureofthisdensity-dependentincreasein
persisters is unknown but is likely to be caused by nutrient deple-
tion.Adeterministiccomponentwasrecentlyidentiﬁedinastudy
ofpersisterformationunderconditionsofDNAdamage(35,36).
Fluoroquinolone antibiotics induce the SOS response, and the
LexA repressor, which controls repair functions, was also shown
to regulate transcription of the TisAB TA module (37). A knock-
outmutantofTisBhadasharplyreducedlevelofpersisters,show-
ing that they are mainly produced in a TisB-dependent manner
when the SOS response is activated. TisB is an antimicrobial pep-
tide that apparently forms an ion channel in the membrane, lead-
ing to a drop in proton motive force (PMF) and ATP levels (7),
which would shut down important functions and lead to a dor-
mant state (35).
Knowledgeofpersistersobtainedfromstudiesofotherspecies
formsagoodbasisforinvestigatingthissubjectinM.tuberculosis.
Here we describe M. tuberculosis persisters and their growth-
phase-dependent formation, isolation, and transcriptome analy-
sis.
RESULTS
Characterizing M. tuberculosis persisters. A biphasic pattern of
killing in a time-dependent experiment indicates the presence of
drug-tolerant persisters in a bacterial population (38). Four anti-
biotics with different mechanisms of action were chosen to probe
the presence of persisters in a growing culture of M. tuberculosis
(Fig. 1). Streptomycin is a translational inhibitor (Fig. 1A), isoni-
azid is a prodrug which interferes with mycolic acid and nucleic
acid biosynthesis (Fig. 1B), ciproﬂoxacin is a gyrase inhibitor
(Fig.1C),andrifampinisatranscriptionalinhibitor(Fig.1B).The
killing generally follows a biphasic pattern—rapid death of the
bulk of the population followed by a diminishing killing rate of a
more tolerant subpopulation. In all cases tested, the killing rate
declined by day 7. These results indicate that M. tuberculosis, like
all other bacterial species tested, produces a subpopulation of
drug-tolerant persister cells. Antibiotics require active targets in
order to kill (18), and relatively good survival of M. tuberculosis
persisters suggests that they are dormant. This would agree well
with a recent report of isoniazid having no effect on a dormant
population adapted to microaerophilic conditions of the Wayne
model (39).
Growthphasedependence.Wenextinvestigatedpersisterfor-
mation at different phases of growth. In order to track the level of
persisters, a sample of the growing culture was withdrawn at each
of the designated time points. The sample was split into three
tubes, and the three antibiotics (streptomycin, ciproﬂoxacin, and
D-cycloserine [DCS]) were added, one to each tube. The exposed
samples were incubated (at 37°C) for 7 days in the presence of
antibiotictokillthenonpersistercells(Fig.1).Afterthechallenge,
the cultures were washed and sonicated and the surviving persist-
ers were quantiﬁed by plating for colony counts. The dynamics of
persisterformationweresimilarforallthreeantibiotics(Fig.2).A
low level of persisters was observed at early exponential phases,
followed by a sharp increase in mid-exponential phase and then
levelingoffinstationaryphase.Streptomycin,whichcankillnon-
growing cells, retained killing ability well into stationary phase
(Fig.2A),buteventuallythepopulationbecamecompletelytoler-
ant (see time point at 18 days). In the case of ciproﬂoxacin and
DCS,theentirepopulationbecametolerantbyday14(Fig.2Band
C).TherapidincreaseinM.tuberculosispersistersissimilartothat
seeninotherbacteria(20)andsuggeststhepresenceofaprogram
whichisactivatedathighcelldensity.Therateofpersisterforma-
tion is not directly proportional to growth rate. At early time
points(t1,3and5days),thegrowthratesaresimilar,whilethe
levelofpersisterschangesbyordersofmagnitude.Inearlystation-
ary phase (5 to 12 days), the population is not growing but the
level of persisters is increasing. This indicates that growth rate
alonecannotexplainthedynamicsofpersisterformationandthat
other factors must be involved. The increase in persister levels is
not due to an increase in resistance, as the number of survivors
decreased or stayed unchanged when the culture was incubated
for an additional week, unlike the expected growth in the case of
resistance (data not shown).
Persisterisolationandtranscriptionproﬁling.Wepreviously
reported that persisters could be isolated by lysing a growing cul-
ture of E. coli with ampicillin and collecting surviving cells by
centrifugation(27).DCSwasreportedtoeffectivelylyseM.tuber-
culosis,andweusedthisantibioticforpersisterisolation(40).DCS
was tested by adding the antibiotics to a growing population of
H37Rvatseveralconcentrationsinordertoidentifyoptimalcon-
ditions for persister isolation. A concentration-dependent in-
creaseinkillingleveledoffat~100g/ml,suggestingthatthiswas
anappropriateconcentrationforpersisterisolation(Fig.3A).The
population treated with DCS rapidly lysed, as determined using
optical density (OD) measurements (Fig. 3B).
ThenextstepwastheisolationoftotalRNAfromDCS-treated
culture.Anexponential-phasecultureofM.tuberculosiswaschal-
Keren et al.
2
® mbio.asm.org May/June 2011 Volume 2 Issue 3 e00100-11lenged with 100 g/ml DCS, and RNA was collected at ﬁve time
points,i.e.,beforeDCSaddition(t0)andat1,3,7,and14days(t1,
t3, t7, and t14, respectively). In conjunction with the RNA
extraction,wedeterminedtheODofthecultureandthecolony
count of the surviving persisters (Fig. 3B and C). The culture
was washed, sonicated, serially diluted, and plated on 7H10
plates, and colonies were counted after 3 weeks of incubation
(at37°C).FromFig.3C,itisevidentthatregularcellsaredyingat
a much higher rate (1 log/day, days 0 to 3) than persisters (about
one-halflog/week,days7to14)andthatdays7and14areappro-
priateforisolatingpersisters.TheRNAisolatedfromsamplescol-
lected at four time points was ampliﬁed using the MessageAmp
II-Bacteria kit for prokaryotic RNA ampliﬁcation (Ambion). The
ampliﬁed RNA (aRNA) was hybridized to an Affymetrix array
designed for this project at the Broad Institute. It is based on the
49-5241 Affymetrix chip and contains 8,871 features, including
probes for all protein-coding genes, newly annotated genes (e.g.,
toxin/antitoxin genes), rRNAs, tRNAs, Rfam domains, and tiled
intergenic regions (forward and reverse strands).
The RNA isolated from the sample collected at day 3 was of
poor quality and unsuitable for use, even though the sample had
10timesmorecellsthanthosecollectedatlatertimepoints.Thisis
likelyduetothelargenumbersofdeadanddyingcellsatthistime
point and the consequent degradation of RNA. For this reason,
onlyRNAfromtimepoints0,1,7,and14wasusedforhybridiza-
tion.
Lysing the culture to obtain persisters for transcriptome anal-
ysis may be problematic, since the antibiotic will induce changes
in gene expression. We therefore applied statistical analysis to see
whetherglobalexpressioninsamplescontainingpersisters(days7
and 14) was distinct from that in samples from the earlier time
points. According to hierarchical clustering (MATLAB), one can
see that expression patterns at t0 and t1 cluster together, as do
those at t7 and t14 (Fig. 4B). This is even more apparent in the
principal-component analysis (Fig. 4A), where the expression
proﬁlesfromtheinitialtwotimepoints(t0inredandt1ingreen)
cluster together and are distinct from those of the last two time
points (t7 in blue and t14 in yellow), which also cluster together.
The transcriptomes of t0 and t1 are less similar to each other than
those of t7 and t14, since t1 represents the transcriptome in re-
FIG 1 Killing of M. tuberculosis by antibiotics. An exponentially growing population of M. tuberculosis was exposed to antibiotics at 5, 10, 20, and 50 times the
MIC. (A) Streptomycin (MIC  0.625 g/ml); (B) isoniazid (MIC  0.135 g/ml); (C) ciproﬂoxacin (MIC  0.625 g/ml); (D) rifampin (MIC  0.1 g/ml).
Characterization of M. tuberculosis Persisters
May/June 2011 Volume 2 Issue 3 e00100-11
® mbio.asm.org 3sponse to antibiotics. This means that the addition of antibiotic
does not preclude obtaining meaningful data from transcriptome
analysis of persisters obtained by lysis.
Transcriptome analysis. Analyzing RNA of persisters at t14
relative to cells prior to antibiotic addition (t0) shows a consider-
abledecreaseinexpression.Twohundredeighty-twoand68genes
wereupregulated2-and4-fold,respectively(Pvalue,0.01),
while 1,408 and 628 genes were downregulated 2- and 4-fold,
respectively(seeTableS1inthesupplementalmaterial).Theshut-
down of expression is massive, especially compared to the rela-
tively modest number of genes with increased expression. This
ﬁnding is consistent with results obtained for E. coli persisters
(22). Many of the energy and metabolism pathways (41) were
considerably downregulated (Fig. 5). Data from stationary-phase
and low-oxygen adaptations reveal strong downregulation of res-
piration, glycolysis, electron transport (about 30% of the genes
were downregulated in response to low oxygen), and oxidative
phosphorylation, similarly to what we have previously shown for
E. coli persisters (22, 27). Ribosomal proteins were almost exclu-
FIG 2 Growth stage dependence of persister formation in M. tuberculosis.A
stationary-phase culture of M. tuberculosis was diluted 1:100, and growth and
persister levels were followed over time. Persister levels were determined after
1 week of challenge with streptomycin (SM) (40 g/ml) (A), ciproﬂoxacin
(Cip) (5 g/ml) (B), and D-cycloserine (DCS) (100 g/ml) (C).
FIG 3 Killing of M. tuberculosis by D-cycloserine. An exponentially growing
population of M. tuberculosis was exposed to D-cycloserine at 10, 20, 100, and
400 g/ml (A) and at 100 g/ml (B and C). (B) Optical density (OD600) and
(C)viablecount(CFU/ml)resultsareshown.SamplesforRNAisolationwere
collected at the time points indicated by arrows.
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operon (rpsR2-rpsN2-rpmG1-rpmB2). Note that proteins en-
coded by this operon have not been shown to be part of the ribo-
some (42). Ribosomal proteins were reported to be downregu-
lated in other dormancy models, including starvation (16),
stationarystate,andtheWaynemodel(15).Somewhatunexpect-
edly, glyoxylate metabolism, which is important for survival in
hypoxic conditions (43) and for persistence in mice (43, 44), was
alsodownregulatedinpersisters.Together,theseresultsindicatea
metabolic downshift consistent with some degree of dormancy.
Of special interest is the expression status of the large number
of M. tuberculosis TA modules (32, 45). Ten TA modules were
overexpressed in persisters (see Fig. S1 in the supplemental mate-
rial), including Rv0549c/Rv0550c, Rv2021c/Rv2022c, Rv1989c/
Rv1990c, Rv2865/Rv2866, Rv0918/Rv0919, Rv3180c/Rv3181c,
Rv1955/Rv1956, Rv3188/Rv3189, and Rv2034/Rv2035. Rv1955/
Rv1956, Rv2034/Rv2035, and Rv2022c (toxin) were also upregu-
lated during adaptation to starvation (16) and the enduring hy-
poxic response (EHR) (14). Both the toxin and the antitoxin of
Rv1989c/Rv1990c, Rv2865/Rv2866, and Rv2021c/Rv2022c were
also upregulated in EHR. We have shown that TA modules play a
role in E. coli persisters (22, 25, 35), and it is logical to assume a
similar function in M. tuberculosis persistence.
Acomparisonofexpressionproﬁlesatt7andt14withthatatt1
indicatesgenesthatarespeciﬁcallyupregulatedinpersistersinde-
pendent of the presence of antibiotic. However, a considerable
numberofgenesinducedaftertheadditionofantibiotic(t1)con-
tinue to be expressed in largely dormant persisters at t7 and t14,
suggesting that these genes may also be important for persister
formation and maintenance. We therefore analyzed both groups,
as detailed below.
Inordertoidentifygenesspeciﬁcallyexpressedinpersisters,we
performed hierarchical clustering of the proﬁles of the 68 genes
thatwere4-foldoverexpressedatt14(Fig.6).Clusteranalysisof
the proﬁles was based on similar patterns of gene expression over
time. Each cluster groups genes with similar behaviors over time,
and each line represents a single gene. Clusters 3, 4, and 9 show
genes speciﬁcally upregulated in persisters. In these three clusters
are genes with little or no change in expression between the ﬁrst
two time points (t0 and t1) and with signiﬁcant increases in ex-
pression at the last two time points (t7 and t14). The 15 genes in
these three clusters are listed in Table 1. Seven of these genes en-
code either hypothetical proteins, conserved hypothetical pro-
teins, or conserved membrane proteins. One of the genes in clus-
ter4,whichcodesfortheuniversalstressprotein(UspA,Rv2623),
was previously shown to be important for establishing a chronic
infectioninmice(46).Thealternativestationary-phasesigmafac-
torsigmaFanditscognateanti-sigmafactorRsbW(alsoknownas
UsfX)arebothmembersofcluster3.Theerror-proneDNApoly-
merasegenednaE2isamemberofcluster4.Asimilaranalysiswas
doneusingallgenesthatwere2-foldoverexpressed(282),which
clustered into 16 clusters (Fig. S2). This produced ﬁve interesting
clusters with 56 persister-speciﬁc genes (see Table S1).
There are several in vitro models that are thought to mimic
some aspects of the in vivo conditions during chronic and latent
infections, including models of starvation (16) and hypoxia (10,
14, 15). We compared our results with published data from these
models, and included all genes upregulated at t14 (in persisters).
We used the genes that are upregulated 2-fold in the following
models: (i) nutrient starvation of an exponential-phase culture
that was starved in phosphate-buffered saline (PBS) for 96 h (16);
(ii)theenduringhypoxicresponse(EHR)at7days(14),inwhich
hypoxia was generated by a continuous ﬂow of low oxygen;
(iii) the Wayne model, in which restriction of headspace in the
culture vial leads to nonreplicating persistence (10, 15); and
(iv) the 49 genes of the Dos regulon (14). This comparison is
similar to the one performed by Sherman and colleagues (14),
with the important addition of the persister transcriptome.
Only eight genes of the Dos regulon were overexpressed in
persisters, although this set did not include the master regula-
tor dosR (see Fig. S3 in the supplemental material). This sug-
gests that the Dos regulon is not involved in the formation of
FIG 4 Principal-component analysis and hierarchical clustering of the tran-
scriptome over time. (A) Principal-component analysis of the 24 arrays, per-
formedusingtheCLCGenomicsWorkbench.Redcircles,t0;greencircles,t1;
bluecircles,t7;yellowcircles,t14.Eachpointintheﬁgurerepresentsonearray.
(B)Hierarchicalclusteringofallgenes(rows)andatalltimepoints(columns),
performed in MatLab. Each row represents a gene; each column represents a
time point.
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cluded in further analysis.
A four-dimensional Venn diagram (Fig. 7) summarizes the
differencesandcommonalitiesofthefourmodels,persisters,star-
vation, EHR, and nonreplicating persistence. There are ﬁve genes
that are common to all models and 55 genes that are common to
persistersandatleast2othermodels(TableS2).Ofspecialinterest
aretheﬁvegenesthatareoverexpressedinallmodels.Thesegenes
are Rv0251c (acr2), encoding an -crystallin heat shock protein,
Rv1152, a transcriptional regulator of the gntR family, Rv2497c
(pdhA), encoding a probable pyruvate dehydrogenase compo-
nent, Rv2517c, encoding a hypothetical protein, and Rv3290c
(lat), encoding an L-lysine-epsilon-aminotransferase. Two of
thesegeneswerealsoupregulatedinthestationaryphase,Rv3290c
and Rv1805c.
We have previously suggested that drug tolerance results from
inactivationofthetargetsofantibioticscausedbydormancy(18).
It was interesting to see whether reduction of expression of the
antibiotic targets plays a role in persisters. We found that ribo-
somal proteins are signiﬁcantly downregulated (Fig. 5), which
may contribute to streptomycin tolerance. gyrA and gyrB were
both downregulated (ratios of 0.12 and 0.35, respectively), possi-
bly contributing to ciproﬂoxacin tolerance. katG was upregulated
in persisters (ratio of 1.8), which could result in more isoniazid
activation, but the target inhA was downregulated (ratio of 0.15).
Expression of rpoB, the target of rifampin, did not change signif-
icantly(ratioof1.28).TheproteinlevelofRpoB,however,ismost
likely reduced as a result of the shutdown in ribosomal protein
expression. D-alanine:D-alanine lygase (ddlA) and alanine race-
mase(alr),theDCStargets,werebothslightlydownregulated(ra-
tio of 0.6).
DISCUSSION
Bacteria employ numerous mechanisms, such as stress responses
and antibiotic resistance, that help them survive in a hostile envi-
ronment. A very different and particularly effective strategy is to
produce specialized survivor cells, persisters. This is a hedge-
betting strategy, whereby a small portion of cells enters into dor-
mancy and becomes highly tolerant to killing by antibiotics (18).
FIG 5 Heat maps of energy metabolism and biosynthetic pathways. The relative mean log2 expression of genes in several energy metabolism and biosynthetic
pathways was calculated and visualized over time using Excel.
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in E. coli.
Dormancy was implicated more than 50 years ago (47) in the
pathogenesis of tuberculosis. Latent, asymptomatic carriers can
developanacutediseasedecadesafterinfection,whichpointstoa
dormant form of the pathogen (48). The Wayne model of M. tu-
berculosisdormancyisbasedongradualtransferofthepopulation
into a low-oxygen environment and has been extensively studied.
A number of genes were found to be upregulated in the Wayne
model (15). At the same time, an execution mechanism that gov-
ernsdormancyintheWaynemodelandothershasnotbeeniden-
tiﬁed.Onepossibilityisthatsuchamechanismdoesnotoperatein
these in vitro dormancy models, where the entire population is
forced into a nonreplicating form by external conditions. In con-
trast,persisterscanforminagrowingpopulationandthereislittle
doubtthattheremustbeadormancyprogram,whichsendsthem
down this distinct developmental pathway. Given the prominent
role of persisters in recalcitrant infections caused by a variety of
pathogens(18,20,49),itissurprisingthatsolittleisknownabout
these cells in M. tuberculosis. This study aimed to document per-
sister formation and obtain the persister transcriptome.
As with other pathogens studied, we found that unrelated an-
tibioticsproduceacharacteristicbiphasicpatternofkillingM.tu-
berculosiscellsinatime-dependentmanner.Thisisaclearindica-
tion of the presence of drug-tolerant persisters. Similar behavior
canbeseeninpublishedresultsforM.tuberculosiskillinginvivoin
the mouse model, guinea pig model, and human sputum (43,
50–52).Thelevelofpersistersrisessharplyasthepopulationden-
sity increases, which is also similar to what we have reported pre-
viously with other bacterial species. This is in contrast to a recent
FIG6 Hierarchicalclusteringofproﬁlesofgenesoverexpressedinpersisters.Theproﬁlesofgenesthatwereoverexpressed4-foldatt14relativetot0(Pvalue,
0.01)werehierarchicallyclusteredusingMATLAB.Eachlineintheclustersrepresentstheproﬁleofonegene.Thenumbers1,2,3,and4correspondtot0,t1,
t7,andt14,respectively.Clusters3,4,and9(outlinedinred)representgenesthatarespeciﬁcallyoverexpressedinpersisters,astheirexpressionisunchangedat
the ﬁrst two time points but is upregulated in persisters.
TABLE 1 Genes that are upregulated in persisters 4-fold
Gene cluster Locus tag Gene Functiona
3 Rv2667 clpC2 Possible ATP-dependent protease
ATP-binding subunit
Rv3287c rsbW Anti-sigma factor (also usfX)
Rv3286c sigF Alternate RNA polymerase
sigma factor
Rv2651c Rv2651c Possible phiRv2
prophage protease
Rv0840c pip Probable proline iminopeptidase
4 Rv2662 Rv2662 HP
Rv2666 Rv2666 Probable transposase
for insertion
sequence elementIS1081
Rv0792c Rv0792c Probable transcriptional
regulatory protein (gntr family)
Rv0142 Rv0142 cHP
Rv0837c Rv0837c HP
Rv2661c Rv2661c HP
Rv0849 Rv0849 Probable conserved integral
membrane transport protein
Rv3370c dnaE2 Probable DNA polymerase III
Rv2623 TB31.7 Universal stress protein (UspA like)
9 Rv1707 Rv1707 Probable conserved
transmembrane protein
a HP, hypothetical protein; cHP, conserved hypothetical protein.
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sisterlevelsinM.tuberculosis(29).Inthatstudy,however,samples
from the growing culture were diluted in fresh medium when
challenged with antibiotic, which was likely to reduce persister
levels. Other studies (53, 54) have shown an increase in antibiotic
tolerance in stationary phase, as we report.
Survivalofpersistersinapopulationtreatedwithanantibiotic
suggestsasimplemethodoftheirisolation.DCSlysesregularcells
of M. tuberculosis, and persisters can be simply collected by cen-
trifugation. These cells were then used to obtain a transcription
proﬁle of persisters using an Affymetrix array.
There were ﬁve times more downregulated genes in persisters
thanupregulatedones(1,408versus282).Thegrowthandenergy
metabolism pathways are overwhelmingly downregulated. M. tu-
berculosis persisters appear to have shut down growth and energy
metabolism, consistent with dormancy. This result also matches
our ﬁnding that E. coli persisters show downregulation of biosyn-
thetic and energy-producing functions (22).
The M. tuberculosis transcriptome also pointed to a number of
genes whose expression was upregulated. We were particularly
interestedtoseeifanyTAmodulesareexpressedinM.tuberculosis
persisters. The E. coli persister transcriptome led to the identiﬁca-
tion of a number of TA modules as a dormancy mechanism.
Among these are mRNA endonucleases RelE (27) and MazF (28);
HipA,thekinasethatphosphorylatesandinhibitsEf-Tu(25);and
TisB (35), which forms an ion channel, causing dormancy by de-
creasingPMFandATP.Currently,thereare65TAmoduleslisted
forM.tuberculosisintheTAdatabase(TADB;http://bioinfo-mml
.sjtu.edu.cn/TADB/browse.php).Ofthese,10wereoverexpressed
inM.tuberculosispersisters.Oneofthese,Rv2866,isarelEhomo-
logue and was recently shown to increase drug tolerance when
overexpressed (29).
We used cluster analysis to identify 15 genes speciﬁcally in-
duced in persisters. Some of these genes have been shown to play
a role in persistent infection in mice. UspA is required for long-
termsurvivalandestablishmentofchronicinfectioninmice(46).
ItisalsooneoftheDosregulongenes(55)andwasoverexpressed
in the nonreplicating persistence model in vitro (15). SigF, the
alternative sigma factor, is overexpressed in stationary phase (15)
and during starvation (16). A sigF deletion strain is attenuated in
monocytes and in the murine model of infection (56). The error-
proneDNApolymerasegenednaE2hasbeenshowntobeupregu-
latedinresponsetoDNA-damagingagentsandtocontributetoin
vivo survival (57).
Of special interest are the ﬁve genes that are overexpressed in
all of the models we compared. The gene acr2, which encodes an
-crystallinheatshockprotein,isahomologueofacr1(hspX),one
ofthemostoverexpressedgenesinthehypoxiamodel(58).Thelat
gene is part of the sigG regulon (59), and sigG is upregulated in
persisters (see Table S1 in the supplemental material). Addition-
ally, lat is upregulated in stationary phase (15), another non-
growth model.
Genes that are overexpressed in persisters could be used as
reporters to capture naive persisters, prior to the addition of anti-
biotic. Placing a ﬂuorescent protein under the control of a pro-
moter of such an overexpressed gene will enable isolation of per-
sistersbycellsorting.Atranscriptomeofsuchnaivepersisterswill
showhowmuch(orhowlittle)theexpressionproﬁleisaffectedby
the addition of an antibiotic.
Our results indicate that persisters isolated from a growing
culture of M. tuberculosis are in a state of dormancy and express a
small set of genes. Since persisters form in both growing and
stationary-phaseculturesinvitro,theymustbeproducedinvivoas
well. Importantly, M. tuberculosis resides in a granuloma, pro-
tected from the immune system. Persisters that will survive expo-
sure to an antibiotic will then be able to repopulate the infection
(Fig. 8), necessitating a lengthy course of therapy.
The persister signature transcription proﬁle identiﬁed in this
study will enable comparisons with dormant cells in vivo. Such
comparisonswilltestthepersisterhypothesisoftuberculosisdor-
mancy.Thisstudywillalsoenabletestingofcandidategenes,such
as TA modules expressed in persisters, for their role in executing
dormancy.
MATERIALS AND METHODS
Strains and culture conditions. Mycobacterium tuberculosis H37Rv was
cultured at 37°C in 7H9 medium supplemented with OADC (oleic acid-
albumin-dextrose-catalast), glycerol, and Tween 80. 7H10 medium sup-
plemented with OADC and glycerol was used as the solid medium.
Antibiotickillingexperiments.FreezerstocksofH37Rvwerediluted
1:100into7H9mediumandculturedfor2weeks.The2-week-oldculture
was diluted 1:100 and grown to mid-exponential phase (OD600, 0.6 to
0.8). Antibiotics were added at the desired concentration, and the culture
was returned to the 37°C shaker for up to 14 days. At the designated time
points, a sample was removed, washed, sonicated to break up clumps
(XL2020; Misonix), serially diluted, and spot plated for CFU count. All
experiments were performed with three biological replicates.
Growth phase dependence. A 2-week-old culture was diluted 1:100
into 7H9 medium. At the designated time point, a sample was removed
anddividedintwo.Oneportionwassonicated(XL2020;Misonix),serially
diluted,andspotplatedforCFUcounts.Theotherportionwaschallenged
with antibiotics for 1 week as described above.
Persister isolation and RNA extraction. A 2-week-old culture was
diluted 1:100 into 7H9 medium and cultured until it reached mid-
exponentialphase(OD600,0.75;~1108CFU/ml).DCSwasaddedtothe
culture at a concentration of 100 g/ml. At the designated time points, a
sample was removed and divided into three portions for determining the
CFU count and OD600 and for RNA isolation. Two volumes of RNA
Protect (Qiagen) was added to the cell suspension, which was then cen-
FIG 7 Venn diagram comparing four models of dormancy. Per, persisters
(representingourdata);EHR,enduringhypoxicresponse(hypoxiabycon-
tinuous ﬂow of low oxygen); Sta, starvation (starving exponential-phase
culture in PBS); NRP, nonreplicating persistence (the Wayne model of
hypoxia by restriction of headspace).
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(MP Biochemicals), transferred into bead beater tubes (lysing matrix B;
MP Biochemicals), and disrupted in the bead beater (FastPrep-24; MP
Biochemicals) for 45 s at maximum power (6.5). The samples were cen-
trifugedfor1minat13,000rpmtosedimentthebeadsandcelldebris.The
supernatant was transferred into a tube containing 300 l chloroform.
The contents were mixed vigorously by inverting the tube for 1 min and
occasionally inverting it for an additional 5 min. The tubes were centri-
fuged for 15 min at 13,000 rpm. The aqueous phase was transferred to
anothertube,and800lofisopropanolwasadded.TheRNAwasprecip-
itated overnight at 80°C and then pelleted by centrifugation for 10 min
at 13,000 rpm. The pellet was washed with 70% ethanol, air-dried, and
resuspended in water. The isolated RNA was cleaned by running it
through an RNeasy column (Qiagen).
Microarray analysis. Expression data were obtained using an Af-
fymetrix M. tuberculosis chip in accordance with the manufacturer’s pro-
tocol. Brieﬂy, the total RNA from the time series experiments was nor-
malized to 25 ng/l and ampliﬁed using the MessageAmp II-Bacteria kit
for prokaryotic RNA ampliﬁcation (Life Technologies). The aRNA was
labeled, fragmented, and hybridized to the custom-designed GeneChip
MTbH37Rva520730F (PN520730). Washing and staining were per-
formedontheGeneChipﬂuidicsstation,andtheGeneChipScanner3000
wasusedforscanningthearrays.Affymetrix.celﬁleswereprocessesedand
converted into .txt ﬁles by the RMA (robust multiarray analysis) method
using the Affy package in R (60). Hierarchical clustering of the arrays was
performed in MatLab, and principal-component analysis was performed
in the CLC Genomics Workbench. The time course gene clustering was
done in MatLab, and the heat maps were generated in Excel.
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